Free Trial

Amrize Ltd (NYSE:AMRZ) Given Average Rating of "Moderate Buy" by Analysts

Amrize logo with Basic Materials background
Image from MarketBeat Media, LLC.

Key Points

  • Analysts give Amrize a consensus "Moderate Buy" rating from 17 analysts (10 buy, 6 hold, 1 strong buy) with an average 12‑month price target of about $64.07, and some firms like JPMorgan recently lifting targets to $70.
  • Latest quarter showed an EPS beat at $0.62 (vs. $0.59 expected) but revenue missed at $2.84B (vs. $2.95B) and was down 0.4% year‑over‑year; the stock trades near $57.56 with a market cap of $31.84B and a PE of 23.4.
  • Insiders increased holdings recently—CEO purchased 60,000 shares and the CFO bought 4,250 shares—and the company declared a $0.44 dividend (ex‑dividend April 24, payable May 4).
  • Interested in Amrize? Here are five stocks we like better.

Shares of Amrize Ltd (NYSE:AMRZ - Get Free Report) have received a consensus recommendation of "Moderate Buy" from the seventeen analysts that are presently covering the company, Marketbeat.com reports. Six analysts have rated the stock with a hold recommendation, ten have issued a buy recommendation and one has issued a strong buy recommendation on the company. The average 12-month price objective among analysts that have updated their coverage on the stock in the last year is $64.0714.

Several equities analysts have recently weighed in on the company. Bank of America set a $58.00 price target on Amrize in a research report on Monday, January 12th. JPMorgan Chase & Co. lifted their price target on Amrize from $60.00 to $70.00 and gave the company an "overweight" rating in a research report on Thursday, March 5th. Wall Street Zen upgraded Amrize from a "sell" rating to a "hold" rating in a research report on Sunday, March 1st. Berenberg Bank set a $70.00 price target on Amrize in a research report on Thursday, February 19th. Finally, UBS Group lifted their price target on Amrize from $53.00 to $57.00 and gave the company a "neutral" rating in a research report on Thursday, January 8th.

Check Out Our Latest Stock Analysis on AMRZ

Amrize Stock Performance

Shares of AMRZ opened at $57.56 on Friday. The firm has a market cap of $31.84 billion and a PE ratio of 23.40. The stock's fifty day moving average price is $58.21 and its two-hundred day moving average price is $54.63. The company has a debt-to-equity ratio of 0.37, a current ratio of 1.64 and a quick ratio of 1.10. Amrize has a 1 year low of $44.12 and a 1 year high of $65.94.

Amrize (NYSE:AMRZ - Get Free Report) last announced its quarterly earnings results on Tuesday, February 17th. The company reported $0.62 earnings per share for the quarter, beating the consensus estimate of $0.59 by $0.03. The company had revenue of $2.84 billion during the quarter, compared to analysts' expectations of $2.95 billion. The company's revenue was down .4% compared to the same quarter last year. On average, equities research analysts forecast that Amrize will post 2.76 EPS for the current year.

Amrize Announces Dividend

The business also recently declared a dividend, which will be paid on Monday, May 4th. Stockholders of record on Monday, April 27th will be given a $0.44 dividend. The ex-dividend date is Friday, April 24th.

Insider Buying and Selling

In other Amrize news, CFO Ian A. Johnston bought 4,250 shares of Amrize stock in a transaction that occurred on Tuesday, March 10th. The stock was acquired at an average cost of $58.94 per share, for a total transaction of $250,495.00. Following the completion of the transaction, the chief financial officer directly owned 25,110 shares in the company, valued at $1,479,983.40. This represents a 20.37% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Jan Philipp Jenisch bought 60,000 shares of the firm's stock in a transaction on Friday, March 6th. The stock was acquired at an average price of $58.05 per share, for a total transaction of $3,483,000.00. Following the completion of the purchase, the chief executive officer directly owned 1,703,582 shares in the company, valued at approximately $98,892,935.10. The trade was a 3.65% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Insiders bought 77,834 shares of company stock valued at $4,511,344 in the last 90 days. Corporate insiders own 0.54% of the company's stock.

Institutional Trading of Amrize

A number of large investors have recently modified their holdings of the business. Twin City Private Wealth LLC bought a new stake in shares of Amrize during the 1st quarter valued at about $558,000. CHICAGO TRUST Co NA boosted its position in shares of Amrize by 27.4% during the 1st quarter. CHICAGO TRUST Co NA now owns 10,643 shares of the company's stock valued at $596,000 after acquiring an additional 2,292 shares during the last quarter. USS Investment Management Ltd boosted its position in shares of Amrize by 6.9% during the 1st quarter. USS Investment Management Ltd now owns 92,133 shares of the company's stock valued at $5,018,000 after acquiring an additional 5,921 shares during the last quarter. Harbor Investment Advisory LLC boosted its position in shares of Amrize by 126.7% during the 1st quarter. Harbor Investment Advisory LLC now owns 15,870 shares of the company's stock valued at $889,000 after acquiring an additional 8,870 shares during the last quarter. Finally, Pictet Asset Management Holding SA boosted its position in shares of Amrize by 4.7% during the 1st quarter. Pictet Asset Management Holding SA now owns 5,216,765 shares of the company's stock valued at $283,017,000 after acquiring an additional 234,731 shares during the last quarter.

Amrize Company Profile

(Get Free Report)

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.

Featured Articles

Analyst Recommendations for Amrize (NYSE:AMRZ)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Amrize Right Now?

Before you consider Amrize, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amrize wasn't on the list.

While Amrize currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines